Document is current
Any future updates will be listed below
-
Authors
Baghai Arassi, Maral https://orcid.org/0000-0002-8957-7767
Fisch, Nora
Feißt, Manuel https://orcid.org/0000-0002-5016-9731
Krupka, Kai https://orcid.org/0000-0002-0409-5196
Höcker, Britta https://orcid.org/0000-0003-4131-2273
Fichtner, Alexander https://orcid.org/0000-0002-9939-4059
Kanzelmeyer, Nele https://orcid.org/0000-0002-4865-4906
König, Jens https://orcid.org/0000-0002-9732-8656
Melk, Anette https://orcid.org/0000-0002-8164-6318
Oh, Jun https://orcid.org/0000-0003-1846-675X
Pape, Lars https://orcid.org/0000-0002-3635-6418
Weber, Lutz T. https://orcid.org/0000-0003-4116-598X
Weitz, Marcus https://orcid.org/0000-0002-1696-5646
Tönshoff, Burkhard https://orcid.org/0000-0002-6598-6910
,
-
Funding
Funding for this research was provided by:
European Society for Paediatric Nephrology
Chiesi Deutschland
Medizinischen Fakultät Heidelberg, Universität Heidelberg
Universitätsklinikum Heidelberg
- License Information
-
More Information
Article History
Received: 17 April 2025
Revised: 23 May 2025
Accepted: 11 June 2025
First Online: 21 July 2025
Declarations
:
: Ethics committee approval was obtained from all participating centers, with the primary approval granted by the Ethics Committee of the Medical Faculty of the University of Heidelberg (approval number: S-388/2010). The study was conducted in accordance with the principles of the Declaration of Helsinki and the Istanbul Declaration on Organ Trafficking and Transplant Tourism and adhered to the STROBE guidelines ( , Supplementary Methods).
: Burkhard Tönshoff has received research grants from Novartis, Astellas, and Chiesi and consulting fees from Bristol-Myers Squibb, CSL Behring Biotherapies for Life, Vifor, and Chiesi. The other authors declare no disclosures.
